Serum paraoxonase 1 activity is decreased in thyroid dysfunction

被引:48
作者
Azizi, F [1 ]
Raiszadeh, F [1 ]
Solati, M [1 ]
Etemadi, A [1 ]
Rahmani, M [1 ]
Arabi, M [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Tehran 19395, Iran
关键词
paraoxonase; oxidation; lipoproteins; apolipoproteins; hyperthyroidism; hypothyroidism;
D O I
10.1007/BF03347350
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changes in serum lipid and lipoprotein concentrations occur frequently in disorders of thyroid function. LDL-cholesterol (LDL-C) oxidation susceptibility is higher in these patients than in normal population. This study aims at assessing lipids, lipoproteins, apolipoproteins and serum paraoxonase 1(PON1) activity in patients with thyroid dysfunction. Ninety-nine patients with thyroid dysfunction, (49 hypothyroid and 50 hyperthyroid) were compared with 2 separately age- and sex-matched control groups. A fasting blood sample was obtained and serum total cholesterol, triglycerides, apolipoproteins A-I and B, and PON1 activity were measured. In hyperthyroid patients, significantly lower PON1 activity (45+/-23 vs 67+/-37 IU/ml, p<0.001), triglycericles (112+/-53 vs 166+/-130 mg/dl, p<0.05), apolipoprotein A-I (137+/-26 vs 154+/-21 mg/dl, p<0.001) and apolipoprotein B (75+/-18 vs 86+/-25 mg/dl, p<0.05) were found. Hypothyroid patients had lower POW activity (46+/-21 vs 64+/-32 IU/ml, p<0.005) compared with controls, and higher total cholesterol (224+/-69 vs 185+/-41 mg/dl, p<0.001), LDL-C (133+/-59 vs 93+/-36 mg/dl, p<0.001), and apolipoprotein B (107+/-37 vs 84+/-23 mg/dl, p<0.001). The results show significant changes of lipid levels in thyroid dysfunction. In addition, a significant reduction in PON1 activity was observed in both hyper- and hypothyroid patients. Increased LDL-C oxidation in thyroid dysfunction observed in other studies, at least to some extent, can be attributed to reduced PON1 activity. (C) 2003, Editrice Kurtis.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 51 条
[1]   SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].
ABBOTT, CA ;
MACKNESS, MI ;
KUMAR, S ;
BOULTON, AJ ;
DURRINGTON, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818
[2]  
ABRAMS JJ, 1981, J LIPID RES, V22, P323
[3]   PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THYROID-DISEASE [J].
AGDEPPA, D ;
MACARON, C ;
MALLIK, T ;
SCHNUDA, ND .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (05) :726-729
[4]   LDL/HDL-CHANGES IN SUBCLINICAL HYPOTHYROIDISM - POSSIBLE RISK-FACTORS FOR CORONARY HEART-DISEASE [J].
ALTHAUS, BU ;
STAUB, JJ ;
RYFFDELECHE, A ;
OBERHANSLI, A ;
STAHELIN, HB .
CLINICAL ENDOCRINOLOGY, 1988, 28 (02) :157-163
[5]   LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN SUBCLINICAL HYPOTHYROIDISM - EFFECT OF LEVOTHYROXINE THERAPY [J].
AREM, R ;
PATSCH, W .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (10) :2097-2100
[6]   LIPID AND LIPOPROTEIN PATTERN IN THYROID-DYSFUNCTION AND THE EFFECT OF THERAPY [J].
AVIRAM, M ;
LUBOSHITZKY, R ;
BROOK, JG .
CLINICAL BIOCHEMISTRY, 1982, 15 (01) :62-66
[7]  
Azizi F., 2000, CVD PREVENTION INTER, V3, P242
[8]   Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy [J].
Becerra, A ;
Bellido, D ;
Luengo, A ;
Piédrola, G ;
De Luis, DA .
CLINICAL NUTRITION, 1999, 18 (05) :319-322
[9]  
BOBERG J, 1984, ACTA MED SCAND, V215, P453
[10]   EFFECT OF DIETARY MONOUNSATURATED AND POLYUNSATURATED FATTY-ACIDS ON THE SUSCEPTIBILITY OF PLASMA LOW-DENSITY LIPOPROTEINS TO OXIDATIVE MODIFICATION [J].
BONANOME, A ;
PAGNAN, A ;
BIFFANTI, S ;
OPPORTUNO, A ;
SORGATO, F ;
DORELLA, M ;
MAIORINO, M ;
URSINI, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (04) :529-533